Literature DB >> 22414555

Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation.

Nan Che1, Xia Li, Shiliang Zhou, Rui Liu, Dongyan Shi, Liwei Lu, Lingyun Sun.   

Abstract

Mesenchymal stem cells (MSCs) may be obtained from umbilical cord as an abundant and noninvasive source. However, the immunomodulatory properties of umbilical cord-MSCs (UC-MSCs) were poorly studied. In this study, we aimed to investigate the effects of UC-MSCs on B-cell proliferation and differentiation. UC-MSCs were found to suppress the proliferation of B cells isolated from murine spleen. Moreover, UC-MSCs markedly suppressed B-cell differentiation as shown by the decreased number of CD138+cells and reduced levels of IgM and IgG production in coculture. As revealed by transwell experiments, soluble factors produced by UC-MSCs might be involved in mediating B-cell suppression. The Blimp-1 mRNA expression was suppressed whereas the PAX-5 mRNA expression was induced in coculture. Finally, UC-MSCs modified the phosphorylation pattern of Akt and p38 pathways, which were involved in B-cell proliferation and differentiation. These results may further support the potential therapeutic use of UC-MSCs in treating autoimmune disorders.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414555     DOI: 10.1016/j.cellimm.2012.02.004

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  29 in total

Review 1.  Interactions between mesenchymal stem cells and the immune system.

Authors:  Na Li; Jinlian Hua
Journal:  Cell Mol Life Sci       Date:  2017-02-18       Impact factor: 9.261

2.  Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration.

Authors:  Maria Rosa Todeschi; Rania El Backly; Chiara Capelli; Antonio Daga; Eugenio Patrone; Martino Introna; Ranieri Cancedda; Maddalena Mastrogiacomo
Journal:  Stem Cells Dev       Date:  2015-03-18       Impact factor: 3.272

Review 3.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

4.  Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.

Authors:  Mai Barakat; Abdelaziz M Hussein; Mohamed F Salama; Amira Awadalla; Nashwa Barakat; Mohamed Serria; Mohamed El-Shafey; Mohamed El-Sherbiny; Mohamed A El Adl
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

5.  Harnessing the anti-inflammatory properties of stem cells for transplant therapy in hemorrhagic stroke.

Authors:  Sydney Corey; Brooke Bonsack; Matt Heyck; Alex Shear; Nadia Sadanandan; Henry Zhang; Cesar V Borlongan
Journal:  Brain Hemorrhages       Date:  2020-01-22

6.  Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.

Authors:  Kapka Miteva; Sophie Van Linthout; Hans-Dieter Volk; Carsten Tschöpe
Journal:  Stem Cells Int       Date:  2013-06-19       Impact factor: 5.443

7.  Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism.

Authors:  Yong-Tao Lv; Yun Zhang; Min Liu; Jia-na-ti Qiuwaxi; Paul Ashwood; Sungho Charles Cho; Ying Huan; Ru-Cun Ge; Xing-Wang Chen; Zhao-Jing Wang; Byung-Jo Kim; Xiang Hu
Journal:  J Transl Med       Date:  2013-08-27       Impact factor: 5.531

8.  Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.

Authors:  Andrea Lindenmair; Tim Hatlapatka; Gregor Kollwig; Simone Hennerbichler; Christian Gabriel; Susanne Wolbank; Heinz Redl; Cornelia Kasper
Journal:  Cells       Date:  2012-11-12       Impact factor: 6.600

9.  Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in B lymphocytes.

Authors:  D-S Lee; T G Yi; H-J Lee; S-N Kim; S Park; M-S Jeon; S U Song
Journal:  Cell Death Dis       Date:  2014-04-24       Impact factor: 8.469

10.  Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.

Authors:  Xiuying Li; Jinping Bai; Xiaofeng Ji; Ronggui Li; Yali Xuan; Yimin Wang
Journal:  Int J Mol Med       Date:  2014-06-25       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.